CURE vs VTI
Direxion Daily Healthcare Bull 3X ETF vs Vanguard Morningstar Total Stock Market ETF
Which is better, CURE or VTI?
Multi Alternative against Large Cap Blend.
VTI has a lower expense ratio. CURE led over 1Y and the full window, VTI over 3Y and 5Y.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | CURE | VTI |
|---|---|---|
| Expense Ratio | 0.94% | 0.03%Best |
| AUM | $184M | $666.9B |
| Dividend Yield | 1.06% | 1.07% |
| Holdings | 67 | 3,543 |
| YTD Return | +12.46% | +12.95%Best |
| 1Y Return | +57.35%Best | +19.17% |
| 3Y Return (annualized) | +10.38% | +20.86%Best |
| 5Y Return (annualized) | +0.47% | +11.72%Best |
| Volatility (annualized) | 41.9% | 14.7%Best |
| Max Drawdown | -69.2% | -35.0%Best |
| $10,000 over 5 years | $10,237 | $17,404Best |
| Fund Family | Direxion Shares ETF Trust | Vanguard (US) |
| Category | Alternative | Equity |
| Style | Multi Alternative | Large Cap Blend |
| Inception | Jun 15, 2011 | May 24, 2001 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown are measured over the window both funds cover: Jun 15, 2011 to Sep 8, 2026 (15.2 years).
CURE vs VTI growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 15.2 years both funds cover.
CURE vs VTI Performance
Direxion Daily Healthcare Bull 3X ETF (CURE) is an ETF from Direxion Shares ETF Trust and Vanguard Morningstar Total Stock Market ETF (VTI) is an ETF from Vanguard (US). Over the past year CURE returned +57.35% while VTI returned +19.17%. Year to date, CURE is up 12.46% versus a gain of 12.95% for VTI.
Over three years, CURE compounded at +10.38% per year against +20.86% for VTI; over five years the annualized figures are +0.47% and +11.72% respectively. Across the full 15-year window we track, CURE has the edge at +24.09% annualized vs +12.74%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CURE has been the more volatile fund, with annualized monthly volatility of 41.9% compared with 14.7% for VTI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -69.2% for CURE and -35.0% for VTI. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.73. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CURE charges 0.94% per year while VTI charges 0.03%. On a $10,000 position that is $94 vs $3 annually, a gap of $91 per year that compounds over a long holding period. On income, CURE currently yields 1.06% against 1.07% for VTI.
Holdings Overlap
We hold position weights for 62 holdings in CURE and 2,788 in VTI, totalling 92.4% and 92.3% of the two funds. Neither is a share of a fund we can divide by, so no overlap percentage is shown here. Within what we can see, 56 positions appear in both.
56 positions in common, counted across the 62 positions we hold weights for in CURE and 2,788 in VTI, against full books of 67 and 3,543.
Top Shared Holdings
| Stock | Weight in CURE | Weight in VTI | Difference |
|---|---|---|---|
| LLYEli Lilly & Co. | 10.22% | 1.40% | 8.82% |
| JNJJohnson & Johnson - Common | 7.10% | 0.84% | 6.26% |
| ABBVAbbvie Inc. | 4.99% | 0.61% | 4.38% |
| UNHUnitedhealth Group | 4.28% | 0.52% | 3.76% |
| MRKMerck & Co. Inc. | 3.66% | 0.44% | 3.22% |
| AMGNAmgen Inc. | 2.44% | 0.27% | 2.17% |
| TMOThermo Fisherscientific Inc. | 2.43% | 0.26% | 2.17% |
| ABTAbbott Laboratories | 2.13% | 0.22% | 1.91% |
| GILDGilead Sciences Inc | 1.94% | 0.22% | 1.72% |
| PFEPfizer, Inc. | 1.68% | 0.19% | 1.49% |
You are not choosing between two funds in isolation.
Whichever of CURE and VTI you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, CURE or VTI?
CURE has an expense ratio of 0.94% while VTI charges 0.03%. VTI is the cheaper option, by $91 a year on a $10,000 investment.
Which performed better, CURE or VTI?
Over the past year CURE returned +57.35% vs +19.17% for VTI, so CURE leads on 1-year performance. Over the longest common window we track (15 years), CURE annualized +24.09% vs +12.74% for VTI. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, CURE or VTI?
CURE has been the more volatile fund at 41.9% annualized versus 14.7% for VTI. Worst drawdown: CURE -69.2% vs VTI -35.0%.
Should I hold both CURE and VTI?
CURE and VTI have a monthly-return correlation of 0.73, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, CURE or VTI?
CURE yields 1.06% while VTI yields 1.07%, so VTI currently pays the higher dividend yield.
Is VTI better than CURE?
VTI has a lower expense ratio. CURE led over 1Y and the full window, VTI over 3Y and 5Y. Which one suits a particular account depends on what it is for. This is information, not a recommendation.